-+ 0.00%
-+ 0.00%
-+ 0.00%

Redhill Biopharma FY EPS $0.00, Sales $286.000K Down From $8.043M YoY

Benzinga·04/27/2026 12:14:17
Listen to the news
Redhill Biopharma (NASDAQ:RDHL) reported quarterly earnings of $0.00 per share. The company reported $286.000 thousand in sales this quarter. This is a 96.44 percent decrease over sales of $8.043 million the same period last year.